TEXT-EXTRACT 2 filename2.txt October 8, 2024 Dimitar Slavchev Savov Chief Executive Officer Nika Pharmaceuticals, Inc. 2269 Merrimack Valley Avenue Henderson, NV 89044 Re: Nika Pharmaceuticals, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 000-56234 Dear Dimitar Slavchev Savov: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences